What is Pulse Biosciences, Inc.'s EV / sales?

Pulse Biosciences, Inc. (PLSE) reported EV / sales of 1,873.1× in Q1 2026.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Pulse Biosciences, Inc. PLSE EV / sales

EV / sales at other companies

AbbottABT

4.6×-1.0×

Johnson & JohnsonJNJ

6.5×+1.8×

Boston ScientificBSX

7×-1.5×

MedtronicMDT

3.6×-0.4×

Merit Medical SystemsMMSI

2.9×-1.9×

ITG

Integer HoldingsITGR

2.4×-0.8×

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

enterprise value/total revenue=1,873.1×

Based on the most recent quarter.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s EV / sales?: Pulse Biosciences, Inc. (PLSE) reported EV / sales of 1,873.1× in Q1 2026.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.